Pharma pricing models & drug pricing strategy

We help innovative pharma and biotech companies bring their therapies to patients through tailored pricing, reimbursement, and access strategies — ensuring sustainable growth and real impact.

Let’s Talk

What is
Market Access?

Market Access is more than a regulatory step — it’s the bridge between innovation and patients. Even the most advanced medicine won’t make a difference if it doesn’t reach those who need it. Our role is to ensure that therapies enter new markets with the right pricing, reimbursement, and long-term sustainability.

Tailored Market
Access Solutions

Bridging the gap between global innovation and local markets.

Pricing & Reimbursement Strategy

Development of local strategies, including payer engagement plans, pricing models, and reimbursement pathways.

Health Economics  & Value Dossiers

Preparation of cost-effectiveness analyses, pharmacoeconomic models, and value dossiers tailored to national HTA requirements.

HTA  Consulting

Expert guidance through Health Technology Assessment processes across the Baltics, CEE, and Eurasia.

Payer  Engagement

Building trusted dialogue with health authorities, insurers, and decision-makers to accelerate patient access by demonstrating the clinical and economic value of new treatments.

Budget  Impact Models

Localized analyses to demonstrate affordability and long-term savings for healthcare systems.

Talk to an Expert

More Than a Service Provider

Expertise, trust, and tailored solutions that turn innovation into patient access.

Let’s Partner Up